Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids

The systemic administration of paclitaxel (PTX)-based combinatorial therapies is significantly restricted due to the multidrug resistance. Curcumin (CUR) not only inhibits cancer-cell proliferation but also reverses the PTX resistance. However, achieving codelivery of these two drugs is a challenge...

Full description

Bibliographic Details
Main Authors: Sena Karaosmanoglu, Yunsen Zhang, Wenli Zhou, Defang Ouyang, Xianfeng Chen
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/9/12/815
_version_ 1797461398757834752
author Sena Karaosmanoglu
Yunsen Zhang
Wenli Zhou
Defang Ouyang
Xianfeng Chen
author_facet Sena Karaosmanoglu
Yunsen Zhang
Wenli Zhou
Defang Ouyang
Xianfeng Chen
author_sort Sena Karaosmanoglu
collection DOAJ
description The systemic administration of paclitaxel (PTX)-based combinatorial therapies is significantly restricted due to the multidrug resistance. Curcumin (CUR) not only inhibits cancer-cell proliferation but also reverses the PTX resistance. However, achieving codelivery of these two drugs is a challenge due to their poor water solubility. Herein, we synthesized carrier-free PTX NPs by a facile nanoprecipitation method with the help of CUR and other curcuminoids present in turmeric extract. The prepared NPs demonstrated spherical morphologies with high conformational stability. Experimental studies showed that the presence of both bisdemethoxycurcumin and demethoxycurcumin is essential for the successful formation of spherical and monodisperse NPs. Computational studies revealed that the presence of the more sterically available curcuminoids BMC and DMC makes the self-assembly procedure more adaptable with a higher number of potential conformations that could give rise to more monodisperse PTX-CUR NPs. Compared with PTX alone, PTX-CUR NPs have shown comparable therapeutic efficiency in vitro and demonstrated a higher cellular internalization, highlighting their potential for in vivo applications. The successful formation of PTX-CUR NPs and the understanding of how multiple drugs behave at the molecular level also provide guidance for developing formulations for the synthesis of high-quality and effective carrier-free nanosystems for biomedical applications.
first_indexed 2024-03-09T17:18:52Z
format Article
id doaj.art-1101a164c4424c74a80e82c8c8f5509b
institution Directory Open Access Journal
issn 2306-5354
language English
last_indexed 2024-03-09T17:18:52Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Bioengineering
spelling doaj.art-1101a164c4424c74a80e82c8c8f5509b2023-11-24T13:21:31ZengMDPI AGBioengineering2306-53542022-12-0191281510.3390/bioengineering9120815Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of CurcuminoidsSena Karaosmanoglu0Yunsen Zhang1Wenli Zhou2Defang Ouyang3Xianfeng Chen4School of Engineering, Institute for Bioengineering, University of Edinburgh, Edinburgh EH9 3JL, UKState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macao 999078, ChinaDepartment of Medical Oncology, Changzheng Hospital, Naval Medical University, Shanghai 200070, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macao 999078, ChinaSchool of Engineering, Institute for Bioengineering, University of Edinburgh, Edinburgh EH9 3JL, UKThe systemic administration of paclitaxel (PTX)-based combinatorial therapies is significantly restricted due to the multidrug resistance. Curcumin (CUR) not only inhibits cancer-cell proliferation but also reverses the PTX resistance. However, achieving codelivery of these two drugs is a challenge due to their poor water solubility. Herein, we synthesized carrier-free PTX NPs by a facile nanoprecipitation method with the help of CUR and other curcuminoids present in turmeric extract. The prepared NPs demonstrated spherical morphologies with high conformational stability. Experimental studies showed that the presence of both bisdemethoxycurcumin and demethoxycurcumin is essential for the successful formation of spherical and monodisperse NPs. Computational studies revealed that the presence of the more sterically available curcuminoids BMC and DMC makes the self-assembly procedure more adaptable with a higher number of potential conformations that could give rise to more monodisperse PTX-CUR NPs. Compared with PTX alone, PTX-CUR NPs have shown comparable therapeutic efficiency in vitro and demonstrated a higher cellular internalization, highlighting their potential for in vivo applications. The successful formation of PTX-CUR NPs and the understanding of how multiple drugs behave at the molecular level also provide guidance for developing formulations for the synthesis of high-quality and effective carrier-free nanosystems for biomedical applications.https://www.mdpi.com/2306-5354/9/12/815hydrophobic anticancer drugscurcuminpaclitaxelcarrier-free nanoparticlesself-assemblymolecular modeling
spellingShingle Sena Karaosmanoglu
Yunsen Zhang
Wenli Zhou
Defang Ouyang
Xianfeng Chen
Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
Bioengineering
hydrophobic anticancer drugs
curcumin
paclitaxel
carrier-free nanoparticles
self-assembly
molecular modeling
title Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
title_full Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
title_fullStr Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
title_full_unstemmed Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
title_short Synthesis of Carrier-Free Paclitaxel–Curcumin Nanoparticles: The Role of Curcuminoids
title_sort synthesis of carrier free paclitaxel curcumin nanoparticles the role of curcuminoids
topic hydrophobic anticancer drugs
curcumin
paclitaxel
carrier-free nanoparticles
self-assembly
molecular modeling
url https://www.mdpi.com/2306-5354/9/12/815
work_keys_str_mv AT senakaraosmanoglu synthesisofcarrierfreepaclitaxelcurcuminnanoparticlestheroleofcurcuminoids
AT yunsenzhang synthesisofcarrierfreepaclitaxelcurcuminnanoparticlestheroleofcurcuminoids
AT wenlizhou synthesisofcarrierfreepaclitaxelcurcuminnanoparticlestheroleofcurcuminoids
AT defangouyang synthesisofcarrierfreepaclitaxelcurcuminnanoparticlestheroleofcurcuminoids
AT xianfengchen synthesisofcarrierfreepaclitaxelcurcuminnanoparticlestheroleofcurcuminoids